Uploaded May 2018 | Updated September 2026, 2 weeks ago

---

Construction was initiated on the Cell and Gene Therapy Catapult Stevenage Manufacturing Innovation Centre (MIC) in November 2015, and was completed in 2017.

The Stevenage MIC is a 7,700m2 MHRA GMP-compliant facility licensed for clinical and commercial ATMP production. Operating through a unique collaboration model, we work with you to develop your manufacturing processes at scale, speed and according to GMP.

Learn more: ct.catapult.org.uk/facilities/stevenage